ArticleThe Lancet. Oncology2020
Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer.
Eiji Kikuchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2020
Eiji Kikuchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.